Peer Navigation + Kidney Transplant Fast Track for Improving Access to Kidney Transplants in Minority Populations
(AKT-MP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for improving access to kidney transplants in minority populations?
How is the Peer Navigation + Kidney Transplant Fast Track treatment different from other treatments for improving access to kidney transplants?
This treatment is unique because it combines a fast-track process for kidney transplant evaluation with peer navigation, where patients receive guidance from someone who has experienced the transplant process themselves. This approach specifically aims to help minority populations overcome barriers to accessing kidney transplants, which is not typically addressed by standard treatments.12346
What is the purpose of this trial?
Hispanic/Latino (HL) and American Indian (AI) patients are more likely than whites to have kidney failure, but less likely to complete transplant evaluation or receive a kidney transplant (KT), the best treatment for kidney failure. Using comparative effectiveness research methods, we will conduct a pragmatic randomized trial to compare the efficacy and cost- effectiveness of two approaches to help HL and AI patients overcome barriers to completing transplant evaluation and receiving a KT: a streamlined KT evaluation process and a peer-assisted evaluation program; and, we will determine best practices to assist other transplant centers in implementing the better program. Findings from this work may help reduce disparities in transplant evaluation and KT.
Research Team
Larissa Myaskovsky, PhD
Principal Investigator
University of New Mexico
Eligibility Criteria
This trial is for adults over 18 with kidney disease, specifically Hispanic/Latino and American Indian patients at the University of New Mexico. They must be mentally competent and not currently waitlisted at another center or have had a previous kidney transplant. Pregnant women, children under 18, incarcerated individuals, those with recent non-skin cancer or cognitive impairments are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either the Kidney Transplant Fast Track (KTFT) or Peer Navigator (PN) intervention to facilitate kidney transplant evaluation
Follow-up
Participants are monitored for quality of life and ambivalence towards kidney transplant using PROMIS Scale and Decisional Conflict Scale
Treatment Details
Interventions
- Kidney Transplant Fast Track (KTFT)
- Peer Navigation (PN)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Mexico
Lead Sponsor
University of Pittsburgh
Collaborator
University of Massachusetts, Amherst
Collaborator
Case Western Reserve University
Collaborator